Health care startups that raised Series A in North America
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| StimCardio | Los Angeles | Series A | $30.0M | 2026-10-29 |
| Vera Health | San Francisco | Series A | $28.5M | 2026-10-27 |
| Probably Genetic | San Francisco | Series A | $12.0M | 2026-10-15 |
| Parakeet Health | San Francisco | Series A | $10.0M | 2026-10-01 |
| Biotia | Long Island City | Series A | $9.0M | 2026-10-01 |
| ai3Bio | Pittsburgh | Series A | $48.0M | 2026-09-29 |
| Arey | Los Angeles | Series A | $4.2M | 2026-09-22 |
| ImpriMed | Palo Alto | Series A | $10.0M | 2026-09-18 |
8 rows of the CSV in 5 of its 18 columns.
- The 2,376 health care startups in North America whose last round is Series A have raised $56.1B in total.
- 272 of them closed their most recent round in the last 12 months, $7.5B combined.
- The largest of those rounds is Solstice Oncology's $225.0M Series A, dated September 2026.
- The most recent is Signet Therapeutics' $11.5M Series A on 4 November 2026.
- Y Combinator is an investor in 36 of them, more than any other fund.
- Biotech is the most common other sector, with 931 companies (39%).
- 29% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (52% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 2,376| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| StimCardio | StimCardio develops wearable neuromodulation devices for managing cardiac rhythm disorders. | Health care | Los Angeles, United States | Series A | $30.0M | 2026-10-29 | $32.0M | MedTech Innovator, Particular Ventures, Solardis Health Ventures | 1 to 10 | 2018 |
| Vera Health | Vera Health is a software development firm that accelerates evidence-based medicine. | Artificial intelligence | San Francisco, United States | Series A | $28.5M | 2026-10-27 | $29.0M | Y Combinator, Pioneer Fund | 1 to 10 | 2024 |
| Probably Genetic | Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. | Artificial intelligence | San Francisco, United States | Series A | $12.0M | 2026-10-15 | $22.9M | Y Combinator, Khosla Ventures, TenOneTen Ventures +2 | 11 to 50 | 2018 |
| Parakeet Health | Parakeet Health provides an AI contact center agent for healthcare practices. | Artificial intelligence | San Francisco, United States | Series A | $10.0M | 2026-10-01 | $13.0M | Canvas Prime, CoFound Partners, StoryHouse Ventures | 11 to 50 | 2023 |
| Biotia | Biotia is a health tech startup that offers AI solutions to diagnose and control infectious diseases. | Artificial intelligence | Long Island City, United States | Series A | $9.0M | 2026-10-01 | $19.7M | Everywhere Ventures, Sand Hill Angels, Tau Ventures +2 | 11 to 50 | 2016 |
| ai3Bio | ai3Bio develops cancer treatments for patients. | Biotech | Pittsburgh, United States | Series A | $48.0M | 2026-09-29 | $103.0M | UPMC Enterprises | 11 to 50 | 2019 |
| Arey | Arey sells science-driven functional beauty products with a specific focus on grey hair. | Commerce | Los Angeles, United States | Series A | $4.2M | 2026-09-22 | $4.2M | Greycroft, Female Founders Fund | 1 to 10 | 2020 |
| ImpriMed | ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. | Artificial intelligence | Palo Alto, United States | Series A | $10.0M | 2026-09-18 | $44.7M | Plug and Play, Pear VC, Draper Associates +1 | 51 to 100 | 2017 |
| Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Toronto, Canada | Series A | $25.0M | 2026-09-17 | $31.0M | Creative Destruction Lab, Debiopharm Innovation Fund, Benchstrength | 11 to 50 | 2019 |
| Evia Bio | Evia Bio develops non-DMSO cryopreservation solutions for life sciences. | Biotech | Minneapolis, United States | Series A | $5.5M | 2026-09-16 | $5.7M | Newchip Accelerator, Pleasant Bay Capital Partners, Walleye Tank | 1 to 10 | 2019 |
| Mithrl | Mithrl is a software development company that builds custom NGS data workflows on demand. | Artificial intelligence | San Francisco, United States | Series A | $20.0M | 2026-09-15 | $24.0M | Bonfire Ventures | 51 to 100 | 2023 |
| TwoStep Therapeutics | TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. | Biotech | Palo Alto, United States | Series A | $62.5M | 2026-09-09 | $90.1M | NFX, 2048 Ventures, Alexandria Venture Investments +1 | 11 to 50 | 2023 |
| GenHealth.ai | GenHealth.ai provides healthcare solutions using generative AI trained on encoded medical events. | Artificial intelligence | Vienna, United States | Series A | $16.5M | 2026-09-08 | $29.5M | Plug and Play, Craft Ventures, Obvious Ventures | 11 to 50 | 2023 |
| Cradlewise | Cradlewise builds AI-powered cribs with monitoring and soothing features that support infant sleep. | Artificial intelligence | San Francisco, United States | Series A | $12.0M | 2026-09-03 | $19.0M | SOSV, CRV, SOSV HAX +2 | 51 to 100 | 2018 |
| Metriport | Metriport provides tools for accessing, integrating, and analyzing patient records. | Artificial intelligence | San Francisco, United States | Series A | $26.0M | 2026-08-27 | $28.4M | Y Combinator, VentureSouq, Zillionize +1 | 11 to 50 | 2022 |
| Aligned Marketplace | Aligned Marketplace connects self-insured employers with independent advanced primary and specialty care providers. | Commerce | New York, United States | Series A | $20.0M | 2026-08-13 | $31.0M | SV Angel, Liquid 2 Ventures, BoxGroup +2 | 11 to 50 | 2023 |
| Remedium Bio | Remedium Bio develops gene therapy treatments for various diseases. | Biotech | Needham, United States | Series A | $10.0M | 2026-08-10 | $13.8M | National Science Foundation, MicroVentures, Longevitytech.fund +1 | 11 to 50 | 2020 |
| Integrated Biosciences | Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. | Artificial intelligence | Redwood City, United States | Series A | $68.4M | 2026-08-05 | $85.6M | Root Ventures, Reinforced Ventures, Mission BioCapital +2 | 11 to 50 | 2022 |
| Andromeda Surgical | Andromeda Surgical develops autonomous robots that perform surgery with greater consistency and fewer errors. | Artificial intelligence | San Francisco, United States | Series A | $15.0M | 2026-08-04 | $15.6M | Y Combinator, Alumni Ventures, Pioneer Fund +2 | 11 to 50 | 2023 |
| Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Boston, United States | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| Sound Health | Sound Health uses acoustic resonance to provide nasal relief. | Health care | San Francisco, United States | Series A | $12.2M | 2026-07-30 | $21.2M | Tau Ventures, J4.Ventures, Moai Capital +2 | 1 to 10 | 2019 |
| Throne | Throne focuses on gut wellness and hydration maintenance for individuals. | Health care | Austin, United States | Series A | $10.0M | 2026-07-28 | $15.2M | Hustle Fund, Night Capital, Austin Rief Ventures | 1 to 10 | 2023 |
| CARPL.ai | CARPL.ai develops a radiology AI orchestration platform and marketplace for healthcare providers. | Artificial intelligence | San Francisco, United States | Series A | $10.0M | 2026-07-23 | $16.0M | Stellaris Venture Partners | 11 to 50 | 2018 |
| Transcripta Bio | Transcripta Bio develops drugs at an accelerated pace with reduced risk. | Biotech | Palo Alto, United States | Series A | $24.0M | 2026-07-22 | $34.4M | BlueYard Capital, Jazz Venture Partners | 11 to 50 | 2020 |
| TYBR Health | TYBR Health develops a sprayable hydrogel that prevents scarring on internal organs after surgery. | Health care | Houston, United States | Series A | $30.0M | 2026-07-21 | $32.3M | Y Combinator, MedTech Innovator, Asymmetry Ventures +1 | 1 to 10 | 2020 |
| InStockRx | InStockRx connects licensed pharmacies to buy and sell inventory with each other. | Commerce | Boston, United States | Series A | $5.0M | 2026-07-01 | $5.1M | Techstars | 1 to 10 | 2020 |
| Xellar Biosystems | Xellar Biosystems analyzes drug testing and treatment data using artificial intelligence. | Artificial intelligence | Newton, United States | Series A | $29.5M | 2026-06-30 | $93.2M | Legend Capital, Tiantu Capital, Zhengxuan Investment +1 | 11 to 50 | 2022 |
| Ognomy Sleep | Ognomy Sleep provides virtual sleep care through telehealth consultations, home sleep testing, and treatment support. | Health care | Buffalo, United States | Series A | $20.0M | 2026-06-30 | $22.8M | Launch NY | 11 to 50 | 2021 |
| Apothékary | Apothékary offers plant-based alternatives to synthetic supplements and beauty products. | Commerce | Falls Church, United States | Series A | $10.0M | 2026-06-29 | $25.0M | Trousdale Ventures, Stella Capital | 51 to 100 | 2020 |
| Tombot | Tombot develops robotic animals to support individuals and families facing health challenges. | Hardware | Santa Clarita, United States | Series A | $7.0M | 2026-06-25 | $24.1M | Wavemaker 360, 32 Ventures, Stevens Family Trust | 1 to 10 | 2017 |
Table 1. Health care startups that raised Series A in North America: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 2,376.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Zarminali Health | Zarminali Health provides pediatric healthcare services that connect children with primary care and specialists. | Health care | Chicago, United States | Series A | $110.0M | 2026-01-21 | $150.0M | General Catalyst | 101 to 250 | 2024 |
| 2 | Latent | Latent develops medical language models to lower healthcare operational costs. | Health care | San Francisco, United States | Series A | $80.0M | 2026-03-18 | $93.5M | Y Combinator | 11 to 50 | 2022 |
| 3 | Integrated Biosciences | Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. | Artificial intelligence | Redwood City, United States | Series A | $68.4M | 2026-08-05 | $85.6M | Root Ventures, Reinforced Ventures, Mission BioCapital +2 | 11 to 50 | 2022 |
| 4 | TwoStep Therapeutics | TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. | Biotech | Palo Alto, United States | Series A | $62.5M | 2026-09-09 | $90.1M | NFX, 2048 Ventures, Alexandria Venture Investments +1 | 11 to 50 | 2023 |
| 5 | Gilgamesh Pharmaceuticals | Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. | Biotech | New York, United States | Series A | $60.0M | 2026-03-24 | $142.6M | Y Combinator, Alumni Ventures, Gaingels +2 | 11 to 50 | 2019 |
| 6 | Chamber Cardio | Chamber Cardio is a healthcare platform that provides cardiovascular health services. | Health care | Washington, United States | Series A | $60.0M | 2026-02-04 | $68.0M | General Catalyst, City Light Capital, AlleyCorp +2 | 11 to 50 | 2022 |
| 7 | Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Boulder, United States | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| 8 | Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Boston, United States | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| 9 | ai3Bio | ai3Bio develops cancer treatments for patients. | Biotech | Pittsburgh, United States | Series A | $48.0M | 2026-09-29 | $103.0M | UPMC Enterprises | 11 to 50 | 2019 |
| 10 | Thesis Care | Thesis Care provides healthcare services using AI technology. | Artificial intelligence | New York, United States | Series A | $45.0M | 2026-03-25 | $60.0M | Oak HC/FT | 11 to 50 | 2024 |
Table 2. Health care startups that raised Series A in North America: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | 36 | 2% | 8 | Vera Health, Probably Genetic, Metriport |
| 2 | Alumni Ventures | Angel group | Manchester, United States | 25 | 1% | 4 | Andromeda Surgical, eddii, Gilgamesh Pharmaceuticals |
| 3 | Techstars | Startup accelerator | New York, United States | 22 | 1% | 3 | InStockRx, Koda Health, Handl Health |
| 4 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 18 | 1% | 6 | Remedium Bio, Koda Health, EnVision Endoscopy |
| 5 | MassChallenge | Startup accelerator | Boston, United States | 15 | 1% | 2 | EnVision Endoscopy, Condor Software |
| 6 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 13 | 1% | 2 | Probably Genetic, Arpeggio Bio |
| 7 | Plug and Play | Startup accelerator | Sunnyvale, United States | 13 | 1% | 4 | ImpriMed, GenHealth.ai, Condor Software |
| 8 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 13 | 1% | ||
| 9 | Gaingels | Syndicate | Burlington, United States | 12 | 1% | 2 | Latus Bio, Gilgamesh Pharmaceuticals |
| 10 | General Catalyst | Venture capital firm | San Francisco, United States | 11 | 0% | 4 | Highlight, Concurrence, Chamber Cardio |
| 11 | Social Starts | Micro VC fund | San Francisco, United States | 10 | 0% | ||
| 12 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 9 | 0% | ||
| 13 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 8 | 0% | 3 | StimCardio, TYBR Health, Avisi Technologies |
| 14 | Alexandria Venture Investments | Venture capital firm | Pasadena, United States | 8 | 0% | 1 | TwoStep Therapeutics |
| 15 | BoxGroup | Venture capital firm | New York, United States | 8 | 0% | 1 | Aligned Marketplace |
Table 3. Health care startups that raised Series A in North America: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 931 | 39% | $36.4B |
| Software | 595 | 25% | $10.7B |
| Artificial intelligence | 275 | 12% | $6.7B |
| Hardware | 140 | 6% | $1.7B |
| Fintech | 110 | 5% | $1.5B |
| Commerce | 88 | 4% | $1.4B |
| Education | 37 | 2% | $325.8M |
| Energy | 12 | 1% | $246.9M |
| Cybersecurity | 9 | 0% | $118.3M |
Table 4. Health care startups that raised Series A in North America by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 2,376 | 100% | $10.2M |
Table 5. Health care startups that raised Series A in North America by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United States | 2,261 | 95% |
| Canada | 103 | 4% |
| Mexico | 12 | 1% |
Table 6. Health care startups that raised Series A in North America by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| New York | 228 | 10% |
| San Francisco | 217 | 9% |
| Cambridge | 106 | 4% |
| Boston | 97 | 4% |
| San Diego | 69 | 3% |
| Los Angeles | 60 | 3% |
| Palo Alto | 50 | 2% |
| Austin | 43 | 2% |
| Toronto | 34 | 1% |
| Seattle | 34 | 1% |
| Mountain View | 26 | 1% |
| Houston | 25 | 1% |
Table 7. Health care startups that raised Series A in North America by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 0% | $11.5M |
| October 2026 | 25 | 9% | $746.4M |
| September 2026 | 29 | 11% | $929.7M |
| August 2026 | 23 | 8% | $552.8M |
| July 2026 | 21 | 8% | $311.3M |
| June 2026 | 30 | 11% | $708.0M |
| May 2026 | 16 | 6% | $509.2M |
| April 2026 | 25 | 9% | $514.4M |
| March 2026 | 26 | 10% | $672.2M |
| February 2026 | 22 | 8% | $562.4M |
| January 2026 | 22 | 8% | $1.1B |
| December 2025 | 23 | 8% | $605.9M |
| November 2025 | 9 | 3% | $350.1M |
Table 8. Health care startups that raised Series A in North America: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 240 | 10% | $6.6B |
| 2025 | 276 | 12% | $6.8B |
| 2024 | 191 | 8% | $5.6B |
| 2023 | 197 | 8% | $4.4B |
| 2022 | 223 | 9% | $4.1B |
| 2021 | 240 | 10% | $7.3B |
Table 9. Health care startups that raised Series A in North America by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 183 | 8% |
| 2020 to 2022 | 491 | 21% |
| 2015 to 2019 | 792 | 34% |
| 2010 to 2014 | 502 | 21% |
| Before 2010 | 384 | 16% |
Table 10. Health care startups that raised Series A in North America by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 708 | 30% |
| 11 to 50 | 1,218 | 52% |
| 51 to 100 | 226 | 10% |
| 101 to 250 | 119 | 5% |
| 251 to 500 | 25 | 1% |
| 501 to 1,000 | 15 | 1% |
| 1,001 to 5,000 | 15 | 1% |
| 5,001 to 10,000 | 5 | 0% |
| 10,001 or more | 9 | 0% |
Table 11. Health care startups that raised Series A in North America by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in North America. On 16 November 2026 that is 2,376 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 2,376 rows: 337 have no round amount, 0 no city and 328 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in North America whose last round is Series A are on the list?
- 2,376, in the file dated 16 November 2026. 272 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 2,376 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.